{
    "2019-07-30": [
        [
            {
                "time": "2023-08-02",
                "original_text": "[快讯]健帆生物30626万股限售股8月2日解禁 解禁",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "限售股",
                        "解禁",
                        "30626万股",
                        "8月2日"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-08-02",
                "original_text": "健帆生物(300529.SZ)：约3.06亿股限售股8月2日解禁 解禁",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "限售股",
                        "解禁",
                        "3.06亿股",
                        "8月2日"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-08-02",
                "original_text": "健帆生物：3.06亿股限售股解禁，占公司总股本比例73.12% 解禁",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "限售股",
                        "解禁",
                        "3.06亿股",
                        "73.12%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}